| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 87 | 2024 | 3072 | 10.210 |
Why?
|
| Forkhead Transcription Factors | 43 | 2024 | 1611 | 6.220 |
Why?
|
| Thymus Gland | 65 | 2024 | 1241 | 3.810 |
Why?
|
| CD4-Positive T-Lymphocytes | 60 | 2024 | 4369 | 2.630 |
Why?
|
| Transcription Factors | 57 | 2024 | 12121 | 2.560 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 8 | 2024 | 150 | 2.480 |
Why?
|
| Diabetes Mellitus, Type 1 | 49 | 2021 | 3439 | 2.430 |
Why?
|
| Gene Expression Regulation | 57 | 2023 | 11900 | 2.240 |
Why?
|
| Mice, Inbred NOD | 65 | 2023 | 1824 | 2.150 |
Why?
|
| Receptors, Antigen, T-Cell | 52 | 2023 | 2531 | 1.960 |
Why?
|
| T-Lymphocytes | 87 | 2024 | 10188 | 1.860 |
Why?
|
| Autoimmunity | 35 | 2019 | 1355 | 1.800 |
Why?
|
| T-Lymphocyte Subsets | 21 | 2021 | 1805 | 1.790 |
Why?
|
| Mice | 307 | 2024 | 81402 | 1.770 |
Why?
|
| Autoimmune Diseases | 31 | 2021 | 2247 | 1.660 |
Why?
|
| Epithelial Cells | 18 | 2024 | 3661 | 1.530 |
Why?
|
| Islets of Langerhans | 28 | 2017 | 1346 | 1.470 |
Why?
|
| Self Tolerance | 10 | 2015 | 123 | 1.470 |
Why?
|
| Animals | 350 | 2024 | 168253 | 1.450 |
Why?
|
| Histocompatibility Antigens Class II | 69 | 2017 | 1445 | 1.450 |
Why?
|
| Arthritis, Experimental | 13 | 2016 | 291 | 1.400 |
Why?
|
| Immune Tolerance | 25 | 2024 | 2300 | 1.360 |
Why?
|
| Transcription, Genetic | 35 | 2024 | 7597 | 1.300 |
Why?
|
| Mice, Transgenic | 97 | 2022 | 9533 | 1.290 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 23 | 2022 | 800 | 1.190 |
Why?
|
| Single-Cell Analysis | 13 | 2024 | 2413 | 1.170 |
Why?
|
| Mice, Inbred C57BL | 97 | 2024 | 22121 | 1.150 |
Why?
|
| B-Lymphocytes | 33 | 2024 | 4748 | 1.150 |
Why?
|
| Cell Differentiation | 61 | 2024 | 11526 | 1.130 |
Why?
|
| Gene Expression Profiling | 42 | 2024 | 9410 | 1.120 |
Why?
|
| Colon | 6 | 2023 | 1791 | 1.070 |
Why?
|
| Lymphocyte Activation | 29 | 2022 | 5491 | 1.050 |
Why?
|
| Intestines | 7 | 2024 | 1909 | 1.020 |
Why?
|
| Intra-Abdominal Fat | 10 | 2024 | 610 | 0.960 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2016 | 1115 | 0.940 |
Why?
|
| CD8-Positive T-Lymphocytes | 27 | 2023 | 4575 | 0.870 |
Why?
|
| Polyendocrinopathies, Autoimmune | 6 | 2016 | 55 | 0.870 |
Why?
|
| Arthritis | 11 | 2012 | 682 | 0.830 |
Why?
|
| Immunologic Memory | 12 | 2019 | 1359 | 0.790 |
Why?
|
| Digestive System | 2 | 2020 | 244 | 0.770 |
Why?
|
| Autoantigens | 14 | 2010 | 876 | 0.760 |
Why?
|
| Dermatitis | 1 | 2023 | 200 | 0.740 |
Why?
|
| Gene Regulatory Networks | 7 | 2023 | 1739 | 0.740 |
Why?
|
| Genes, MHC Class II | 29 | 2004 | 451 | 0.720 |
Why?
|
| Inflammation | 28 | 2024 | 10746 | 0.720 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2021 | 386 | 0.700 |
Why?
|
| Metagenome | 4 | 2012 | 450 | 0.700 |
Why?
|
| Th17 Cells | 6 | 2024 | 792 | 0.690 |
Why?
|
| Quantitative Trait Loci | 8 | 2015 | 2104 | 0.670 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1485 | 0.660 |
Why?
|
| Models, Immunological | 10 | 2015 | 512 | 0.660 |
Why?
|
| Pancreas | 14 | 2017 | 1684 | 0.640 |
Why?
|
| Arthritis, Rheumatoid | 15 | 2011 | 3759 | 0.640 |
Why?
|
| Gastrointestinal Tract | 3 | 2022 | 831 | 0.640 |
Why?
|
| Immunogenetic Phenomena | 2 | 2016 | 23 | 0.640 |
Why?
|
| Immune System Diseases | 1 | 2021 | 257 | 0.630 |
Why?
|
| Mice, Knockout | 43 | 2021 | 14397 | 0.630 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2013 | 3777 | 0.630 |
Why?
|
| Cytokines | 17 | 2023 | 7377 | 0.620 |
Why?
|
| Allergy and Immunology | 3 | 2012 | 175 | 0.620 |
Why?
|
| Enteric Nervous System | 1 | 2021 | 212 | 0.590 |
Why?
|
| Cell Lineage | 18 | 2014 | 2539 | 0.590 |
Why?
|
| Insulin-Secreting Cells | 7 | 2017 | 898 | 0.580 |
Why?
|
| Organ Culture Techniques | 5 | 2017 | 794 | 0.570 |
Why?
|
| Clostridium | 1 | 2017 | 100 | 0.550 |
Why?
|
| Disease Models, Animal | 36 | 2021 | 18216 | 0.550 |
Why?
|
| Promoter Regions, Genetic | 18 | 2024 | 5778 | 0.540 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2022 | 344 | 0.530 |
Why?
|
| Janus Kinases | 2 | 2016 | 249 | 0.530 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 2189 | 0.520 |
Why?
|
| Homeostasis | 12 | 2024 | 3320 | 0.520 |
Why?
|
| Interleukin-6 | 4 | 2021 | 3209 | 0.510 |
Why?
|
| Monocytes | 5 | 2022 | 2572 | 0.510 |
Why?
|
| Skin Diseases | 2 | 2023 | 1090 | 0.490 |
Why?
|
| Genetic Variation | 13 | 2024 | 6570 | 0.490 |
Why?
|
| Psoriasis | 1 | 2023 | 937 | 0.480 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 1753 | 0.480 |
Why?
|
| Killer Cells, Natural | 8 | 2016 | 2202 | 0.480 |
Why?
|
| Receptors, Interleukin-2 | 4 | 2006 | 562 | 0.470 |
Why?
|
| Diarrhea | 1 | 2021 | 1319 | 0.460 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 69 | 0.450 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 2819 | 0.440 |
Why?
|
| Antibodies | 8 | 2010 | 2421 | 0.440 |
Why?
|
| Flow Cytometry | 24 | 2021 | 5865 | 0.430 |
Why?
|
| Lymphocyte Subsets | 3 | 2011 | 311 | 0.430 |
Why?
|
| Gene Expression | 15 | 2016 | 7582 | 0.430 |
Why?
|
| Immunity, Mucosal | 2 | 2016 | 482 | 0.420 |
Why?
|
| Immune System | 6 | 2023 | 794 | 0.420 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2018 | 0.420 |
Why?
|
| Immunogenetics | 1 | 2012 | 66 | 0.420 |
Why?
|
| Intestinal Mucosa | 4 | 2024 | 3026 | 0.410 |
Why?
|
| Glucose-6-Phosphate Isomerase | 6 | 2010 | 50 | 0.410 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 2014 | 557 | 0.400 |
Why?
|
| Antigens, CD | 16 | 2015 | 4000 | 0.400 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 614 | 0.400 |
Why?
|
| RNA Interference | 2 | 2014 | 2832 | 0.400 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 67 | 0.390 |
Why?
|
| Symbiosis | 6 | 2017 | 294 | 0.380 |
Why?
|
| Organ Specificity | 9 | 2016 | 1956 | 0.380 |
Why?
|
| Regeneration | 7 | 2022 | 1508 | 0.380 |
Why?
|
| Macrophages | 13 | 2024 | 5764 | 0.380 |
Why?
|
| Interleukin-15 | 2 | 2010 | 185 | 0.380 |
Why?
|
| Chromatin | 10 | 2024 | 2951 | 0.370 |
Why?
|
| Calcium Signaling | 1 | 2015 | 733 | 0.370 |
Why?
|
| RNA, Messenger | 19 | 2018 | 12785 | 0.370 |
Why?
|
| Mice, Inbred Strains | 13 | 2016 | 1759 | 0.360 |
Why?
|
| Antigen-Antibody Complex | 3 | 2009 | 513 | 0.360 |
Why?
|
| Peptides | 15 | 2015 | 4338 | 0.360 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2010 | 57 | 0.350 |
Why?
|
| Antigens, Differentiation | 5 | 2006 | 910 | 0.350 |
Why?
|
| DNA-Binding Proteins | 21 | 2020 | 9598 | 0.350 |
Why?
|
| Autoantibodies | 14 | 2012 | 2123 | 0.350 |
Why?
|
| Alleles | 15 | 2023 | 6908 | 0.340 |
Why?
|
| Interleukin-4 | 5 | 2008 | 1130 | 0.340 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2011 | 367 | 0.340 |
Why?
|
| Major Histocompatibility Complex | 19 | 2000 | 927 | 0.340 |
Why?
|
| Adipose Tissue | 8 | 2024 | 3306 | 0.330 |
Why?
|
| Bone Marrow Cells | 5 | 2017 | 2416 | 0.330 |
Why?
|
| Coculture Techniques | 3 | 2024 | 1340 | 0.330 |
Why?
|
| Transforming Growth Factor beta | 4 | 2013 | 1959 | 0.330 |
Why?
|
| Databases, Genetic | 2 | 2020 | 1738 | 0.320 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2007 | 825 | 0.320 |
Why?
|
| Mice, Inbred BALB C | 18 | 2020 | 6206 | 0.320 |
Why?
|
| Antigen Presentation | 12 | 2017 | 1254 | 0.320 |
Why?
|
| Mast Cells | 6 | 2012 | 1391 | 0.320 |
Why?
|
| Biodiversity | 1 | 2011 | 347 | 0.320 |
Why?
|
| Molecular Sequence Data | 52 | 2015 | 17639 | 0.310 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 2013 | 899 | 0.310 |
Why?
|
| Clonal Deletion | 8 | 2012 | 74 | 0.310 |
Why?
|
| Nociceptors | 2 | 2024 | 461 | 0.310 |
Why?
|
| Signal Transduction | 17 | 2024 | 23397 | 0.310 |
Why?
|
| Bacteria | 6 | 2021 | 2217 | 0.300 |
Why?
|
| DNA | 25 | 2023 | 7208 | 0.300 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 224 | 0.300 |
Why?
|
| Cyclophosphamide | 4 | 2021 | 2218 | 0.300 |
Why?
|
| Muscle, Skeletal | 6 | 2020 | 4923 | 0.300 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 980 | 0.300 |
Why?
|
| Transcription Factor RelA | 2 | 2019 | 253 | 0.290 |
Why?
|
| Mutation | 33 | 2023 | 30025 | 0.290 |
Why?
|
| Humans | 121 | 2024 | 760437 | 0.290 |
Why?
|
| Lymph Nodes | 13 | 2023 | 3469 | 0.290 |
Why?
|
| Spleen | 15 | 2021 | 2296 | 0.280 |
Why?
|
| Myeloid Cells | 2 | 2022 | 823 | 0.280 |
Why?
|
| Cells, Cultured | 21 | 2024 | 18955 | 0.280 |
Why?
|
| Interferon Type I | 2 | 2024 | 562 | 0.270 |
Why?
|
| Interferon-gamma | 13 | 2023 | 3157 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 13 | 2022 | 1355 | 0.270 |
Why?
|
| Immunity | 3 | 2014 | 997 | 0.270 |
Why?
|
| Protein Binding | 13 | 2019 | 9340 | 0.270 |
Why?
|
| Interleukin-17 | 4 | 2022 | 907 | 0.260 |
Why?
|
| Antigens | 6 | 2023 | 1446 | 0.260 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 9 | 2020 | 790 | 0.260 |
Why?
|
| Genomics | 5 | 2012 | 5806 | 0.260 |
Why?
|
| Chromosome Mapping | 11 | 2017 | 4630 | 0.260 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 305 | 0.260 |
Why?
|
| Tretinoin | 1 | 2008 | 519 | 0.260 |
Why?
|
| Microarray Analysis | 4 | 2012 | 748 | 0.240 |
Why?
|
| Endocrine System | 1 | 2005 | 114 | 0.240 |
Why?
|
| Adipocytes | 2 | 2024 | 1192 | 0.240 |
Why?
|
| Phenotype | 21 | 2021 | 16585 | 0.240 |
Why?
|
| Amino Acid Sequence | 37 | 2015 | 13445 | 0.240 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 6 | 2022 | 973 | 0.240 |
Why?
|
| DNA, Z-Form | 1 | 2024 | 3 | 0.240 |
Why?
|
| Venoms | 3 | 2015 | 95 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2453 | 0.230 |
Why?
|
| Up-Regulation | 6 | 2010 | 4116 | 0.230 |
Why?
|
| Neuroimmunomodulation | 2 | 2024 | 178 | 0.230 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1089 | 0.230 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2024 | 322 | 0.230 |
Why?
|
| Dendritic Cells | 7 | 2021 | 2725 | 0.230 |
Why?
|
| Joints | 6 | 2010 | 321 | 0.230 |
Why?
|
| Species Specificity | 5 | 2022 | 2417 | 0.230 |
Why?
|
| Interferon Regulatory Factors | 3 | 2021 | 262 | 0.220 |
Why?
|
| Male | 65 | 2024 | 360035 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2014 | 17854 | 0.220 |
Why?
|
| Immunity, Innate | 11 | 2017 | 3059 | 0.220 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2023 | 126 | 0.210 |
Why?
|
| PPAR gamma | 3 | 2018 | 483 | 0.210 |
Why?
|
| Base Sequence | 49 | 2023 | 12449 | 0.210 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 242 | 0.210 |
Why?
|
| Microsatellite Repeats | 3 | 2023 | 785 | 0.210 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2023 | 1636 | 0.210 |
Why?
|
| Capillaries | 1 | 2006 | 755 | 0.210 |
Why?
|
| Complement System Proteins | 2 | 2022 | 788 | 0.200 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 8 | 2000 | 317 | 0.200 |
Why?
|
| Interleukin-2 | 5 | 2021 | 1891 | 0.200 |
Why?
|
| Capillary Permeability | 1 | 2006 | 773 | 0.200 |
Why?
|
| Genetic Vectors | 12 | 2006 | 3392 | 0.200 |
Why?
|
| Interleukin-7 | 3 | 2013 | 142 | 0.200 |
Why?
|
| Cell Proliferation | 11 | 2021 | 10425 | 0.200 |
Why?
|
| Neutrophils | 8 | 2024 | 3764 | 0.200 |
Why?
|
| Complement C3 | 1 | 2024 | 451 | 0.200 |
Why?
|
| Receptors, Immunologic | 3 | 2014 | 1411 | 0.200 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 526 | 0.190 |
Why?
|
| Neurons | 1 | 2021 | 9443 | 0.190 |
Why?
|
| Insulin | 7 | 2017 | 6591 | 0.190 |
Why?
|
| Heligmosomatoidea | 1 | 2021 | 2 | 0.190 |
Why?
|
| H-2 Antigens | 9 | 1997 | 358 | 0.190 |
Why?
|
| DNA Methylation | 1 | 2015 | 4383 | 0.190 |
Why?
|
| Phagocytes | 1 | 2023 | 296 | 0.190 |
Why?
|
| Mice, Inbred CBA | 4 | 2020 | 436 | 0.190 |
Why?
|
| Influenza A virus | 4 | 2022 | 457 | 0.180 |
Why?
|
| Crosses, Genetic | 5 | 2011 | 751 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2008 | 1607 | 0.180 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2021 | 64 | 0.180 |
Why?
|
| Receptors, IgG | 4 | 2012 | 559 | 0.180 |
Why?
|
| DNA Nucleotidylexotransferase | 8 | 1996 | 64 | 0.180 |
Why?
|
| Plasma Cells | 2 | 2017 | 599 | 0.180 |
Why?
|
| Muscle Development | 1 | 2022 | 259 | 0.180 |
Why?
|
| Insulin Resistance | 4 | 2024 | 3956 | 0.170 |
Why?
|
| Genome | 4 | 2021 | 1739 | 0.170 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 359 | 0.170 |
Why?
|
| Interleukin-18 | 1 | 2021 | 249 | 0.170 |
Why?
|
| PPAR alpha | 1 | 2021 | 175 | 0.170 |
Why?
|
| Cluster Analysis | 5 | 2014 | 2711 | 0.170 |
Why?
|
| Proteomics | 3 | 2010 | 3818 | 0.170 |
Why?
|
| Immunosuppressive Agents | 5 | 2021 | 4168 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2019 | 1363 | 0.160 |
Why?
|
| Ebolavirus | 1 | 2022 | 251 | 0.160 |
Why?
|
| Disease Progression | 9 | 2017 | 13484 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1610 | 0.160 |
Why?
|
| Binding Sites | 12 | 2019 | 6042 | 0.160 |
Why?
|
| Retroviridae | 3 | 2006 | 850 | 0.160 |
Why?
|
| Mice, Mutant Strains | 18 | 2014 | 1751 | 0.160 |
Why?
|
| Stromal Cells | 6 | 2024 | 1330 | 0.160 |
Why?
|
| Clonal Anergy | 1 | 2019 | 171 | 0.160 |
Why?
|
| Th2 Cells | 5 | 2012 | 1054 | 0.160 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1250 | 0.160 |
Why?
|
| Lysine | 3 | 2015 | 992 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 16 | 2000 | 964 | 0.150 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2012 | 452 | 0.150 |
Why?
|
| Female | 52 | 2024 | 391875 | 0.150 |
Why?
|
| NIH 3T3 Cells | 2 | 2017 | 671 | 0.150 |
Why?
|
| Human Body | 1 | 2017 | 37 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 183 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2016 | 472 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2019 | 393 | 0.140 |
Why?
|
| Viral Proteins | 2 | 2022 | 1803 | 0.140 |
Why?
|
| Lymphoid Tissue | 5 | 2013 | 445 | 0.140 |
Why?
|
| Obesity | 10 | 2024 | 12918 | 0.140 |
Why?
|
| Interferon-alpha | 1 | 2021 | 920 | 0.140 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 665 | 0.140 |
Why?
|
| HEK293 Cells | 8 | 2021 | 4277 | 0.140 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 2572 | 0.140 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2017 | 106 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2017 | 1647 | 0.140 |
Why?
|
| Polymorphism, Genetic | 10 | 2012 | 4287 | 0.140 |
Why?
|
| Lectins, C-Type | 3 | 2013 | 584 | 0.140 |
Why?
|
| Eukaryotic Cells | 1 | 2017 | 195 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2016 | 476 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2017 | 247 | 0.130 |
Why?
|
| Immunophenotyping | 6 | 2019 | 1870 | 0.130 |
Why?
|
| Interferon-beta | 2 | 2015 | 345 | 0.130 |
Why?
|
| Cell Separation | 4 | 2015 | 1720 | 0.130 |
Why?
|
| Gene Transfer Techniques | 6 | 2000 | 1205 | 0.130 |
Why?
|
| Immunity, Cellular | 3 | 2014 | 1559 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 633 | 0.130 |
Why?
|
| Histocompatibility Antigens | 5 | 2013 | 467 | 0.130 |
Why?
|
| Receptors, CXCR3 | 1 | 2016 | 238 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2019 | 547 | 0.130 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2015 | 42 | 0.130 |
Why?
|
| Serine Endopeptidases | 2 | 2012 | 1021 | 0.130 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 336 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 2018 | 1766 | 0.130 |
Why?
|
| Bacteroidetes | 1 | 2015 | 84 | 0.120 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2013 | 40 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 2 | 2017 | 899 | 0.120 |
Why?
|
| Synovial Membrane | 2 | 2009 | 532 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2017 | 1233 | 0.120 |
Why?
|
| Histones | 3 | 2010 | 2577 | 0.120 |
Why?
|
| Phosphorylation | 6 | 2015 | 8311 | 0.120 |
Why?
|
| Pancreatitis | 2 | 2016 | 1096 | 0.120 |
Why?
|
| Animals, Outbred Strains | 2 | 2010 | 20 | 0.120 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2014 | 36 | 0.120 |
Why?
|
| Integrins | 1 | 2018 | 834 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12127 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 468 | 0.110 |
Why?
|
| Genetics, Population | 3 | 2015 | 939 | 0.110 |
Why?
|
| Models, Molecular | 6 | 2017 | 5427 | 0.110 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 211 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2019 | 855 | 0.110 |
Why?
|
| Lymphopoiesis | 1 | 2014 | 133 | 0.110 |
Why?
|
| Aging | 7 | 2019 | 8689 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 457 | 0.110 |
Why?
|
| Germ-Free Life | 4 | 2017 | 189 | 0.110 |
Why?
|
| Denervation | 1 | 2014 | 263 | 0.110 |
Why?
|
| STAT Transcription Factors | 1 | 2014 | 188 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1790 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2017 | 2858 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 682 | 0.110 |
Why?
|
| Receptors, Complement | 2 | 2012 | 253 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4355 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15820 | 0.110 |
Why?
|
| Epitopes | 14 | 1999 | 2504 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 2016 | 657 | 0.100 |
Why?
|
| Immunoglobulins | 5 | 2000 | 859 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2022 | 4234 | 0.100 |
Why?
|
| Cell Line | 11 | 2014 | 15598 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2016 | 1153 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1406 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 12 | 2013 | 9176 | 0.100 |
Why?
|
| Computational Biology | 3 | 2014 | 3510 | 0.100 |
Why?
|
| Multigene Family | 2 | 2014 | 1077 | 0.100 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 47 | 0.100 |
Why?
|
| Operon | 4 | 1984 | 374 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2014 | 273 | 0.100 |
Why?
|
| Simian virus 40 | 3 | 1984 | 291 | 0.100 |
Why?
|
| Cell Division | 6 | 2004 | 4461 | 0.100 |
Why?
|
| Hindlimb | 1 | 2014 | 509 | 0.100 |
Why?
|
| Adaptive Immunity | 5 | 2017 | 725 | 0.100 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 84 | 0.100 |
Why?
|
| Period Circadian Proteins | 1 | 2012 | 96 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4567 | 0.100 |
Why?
|
| Protein Conformation | 5 | 2017 | 3969 | 0.100 |
Why?
|
| Time Perception | 1 | 2012 | 87 | 0.100 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2010 | 87 | 0.100 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2012 | 174 | 0.100 |
Why?
|
| Metals, Rare Earth | 1 | 2011 | 16 | 0.100 |
Why?
|
| Interleukin-1alpha | 2 | 2010 | 86 | 0.100 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 1900 | 0.100 |
Why?
|
| Mice, Obese | 3 | 2024 | 420 | 0.100 |
Why?
|
| Nobel Prize | 1 | 2011 | 48 | 0.100 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 296 | 0.100 |
Why?
|
| Transformation, Genetic | 2 | 1989 | 192 | 0.090 |
Why?
|
| Antigens, Viral | 3 | 1997 | 987 | 0.090 |
Why?
|
| Fluorescence | 1 | 2013 | 756 | 0.090 |
Why?
|
| Genome-Wide Association Study | 5 | 2014 | 12653 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2049 | 0.090 |
Why?
|
| Kinetics | 7 | 2024 | 6377 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 232 | 0.090 |
Why?
|
| Transgenes | 5 | 2009 | 1009 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2004 | 584 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 3782 | 0.090 |
Why?
|
| Integrases | 2 | 2011 | 516 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 889 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22097 | 0.090 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1992 | 0.090 |
Why?
|
| RNA Splicing | 3 | 2015 | 915 | 0.090 |
Why?
|
| Adoptive Transfer | 3 | 2021 | 819 | 0.090 |
Why?
|
| Biology | 1 | 2012 | 289 | 0.090 |
Why?
|
| Thinness | 2 | 2014 | 490 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2018 | 15867 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 1454 | 0.090 |
Why?
|
| Nuclear Proteins | 6 | 2015 | 5794 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 574 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 867 | 0.090 |
Why?
|
| Antibody Specificity | 3 | 2009 | 1060 | 0.090 |
Why?
|
| Transfection | 10 | 2000 | 5776 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2019 | 262 | 0.080 |
Why?
|
| Science | 1 | 2012 | 239 | 0.080 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 555 | 0.080 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 95 | 0.080 |
Why?
|
| Cell Nucleus | 4 | 2012 | 2906 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 239 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 1035 | 0.080 |
Why?
|
| Lod Score | 1 | 2010 | 602 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 22083 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2012 | 311 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2011 | 787 | 0.080 |
Why?
|
| Antigens, Neoplasm | 4 | 2010 | 1994 | 0.080 |
Why?
|
| Bacteriocins | 1 | 2009 | 88 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2013 | 1755 | 0.080 |
Why?
|
| Skin | 1 | 2023 | 4474 | 0.080 |
Why?
|
| Genes, Reporter | 5 | 2014 | 1528 | 0.080 |
Why?
|
| Tetracycline | 3 | 2005 | 219 | 0.080 |
Why?
|
| Polyethyleneimine | 3 | 1998 | 67 | 0.080 |
Why?
|
| Lymphocytes | 5 | 2006 | 2610 | 0.080 |
Why?
|
| Ovum | 1 | 1989 | 187 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3592 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 377 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 110 | 0.080 |
Why?
|
| NFATC Transcription Factors | 2 | 2011 | 389 | 0.080 |
Why?
|
| Lymphocyte Count | 6 | 2012 | 778 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 617 | 0.080 |
Why?
|
| Consensus Sequence | 2 | 2023 | 365 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1091 | 0.080 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 120 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 589 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2013 | 1967 | 0.080 |
Why?
|
| Androstenes | 1 | 2009 | 181 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2010 | 415 | 0.070 |
Why?
|
| Adipogenesis | 2 | 2024 | 367 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 387 | 0.070 |
Why?
|
| Glycolysis | 1 | 2012 | 832 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 400 | 0.070 |
Why?
|
| Ovalbumin | 5 | 1999 | 672 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 2647 | 0.070 |
Why?
|
| Colonic Neoplasms | 2 | 2018 | 2529 | 0.070 |
Why?
|
| Bone Marrow | 2 | 2017 | 2907 | 0.070 |
Why?
|
| Prodrugs | 1 | 2009 | 261 | 0.070 |
Why?
|
| Th1 Cells | 3 | 2005 | 1037 | 0.070 |
Why?
|
| Genotype | 6 | 2018 | 12976 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1183 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 20078 | 0.070 |
Why?
|
| Epithelium | 2 | 2008 | 1603 | 0.070 |
Why?
|
| Repressor Proteins | 4 | 2013 | 2978 | 0.070 |
Why?
|
| Terminology as Topic | 3 | 2013 | 1534 | 0.070 |
Why?
|
| Stem Cells | 4 | 2016 | 3522 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1135 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1974 | 0.070 |
Why?
|
| Gene Rearrangement | 2 | 2007 | 1125 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2010 | 1183 | 0.070 |
Why?
|
| Cell Death | 3 | 2003 | 1664 | 0.070 |
Why?
|
| Genome, Human | 2 | 2017 | 4423 | 0.070 |
Why?
|
| Immunity, Active | 1 | 2006 | 58 | 0.070 |
Why?
|
| Interleukin-12 | 2 | 2007 | 583 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2012 | 944 | 0.070 |
Why?
|
| Lung | 3 | 2022 | 9973 | 0.070 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 148 | 0.070 |
Why?
|
| Chemokines | 1 | 2010 | 960 | 0.070 |
Why?
|
| Interleukin-1beta | 2 | 2010 | 997 | 0.070 |
Why?
|
| Leukocytes | 1 | 2014 | 2024 | 0.070 |
Why?
|
| Data Display | 1 | 2006 | 175 | 0.060 |
Why?
|
| Child | 5 | 2022 | 80086 | 0.060 |
Why?
|
| beta 2-Microglobulin | 5 | 1999 | 329 | 0.060 |
Why?
|
| Spermatozoa | 1 | 1989 | 630 | 0.060 |
Why?
|
| Protein Multimerization | 3 | 2023 | 982 | 0.060 |
Why?
|
| Endocarditis | 1 | 2009 | 350 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2014 | 2485 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 901 | 0.060 |
Why?
|
| DNA, Recombinant | 6 | 1989 | 455 | 0.060 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 602 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1084 | 0.060 |
Why?
|
| Dimerization | 2 | 2022 | 891 | 0.060 |
Why?
|
| Ligands | 5 | 2004 | 3270 | 0.060 |
Why?
|
| Genes | 6 | 1983 | 1844 | 0.060 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 39 | 0.060 |
Why?
|
| Diabetes Mellitus | 4 | 2011 | 5835 | 0.060 |
Why?
|
| Haplotypes | 8 | 2010 | 2773 | 0.060 |
Why?
|
| Oncostatin M | 1 | 2024 | 42 | 0.060 |
Why?
|
| Luciferases | 4 | 2006 | 714 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 862 | 0.060 |
Why?
|
| Histamine | 1 | 2006 | 497 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3792 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2006 | 472 | 0.060 |
Why?
|
| Research | 1 | 2012 | 1977 | 0.060 |
Why?
|
| Hybridomas | 9 | 1998 | 442 | 0.060 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2024 | 612 | 0.060 |
Why?
|
| Interleukins | 1 | 2008 | 782 | 0.060 |
Why?
|
| Lentivirus | 1 | 2006 | 508 | 0.060 |
Why?
|
| Gastritis | 1 | 2005 | 199 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2010 | 2612 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2020 | 739 | 0.050 |
Why?
|
| Adult | 10 | 2022 | 220781 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2004 | 198 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1922 | 0.050 |
Why?
|
| Tarsus, Animal | 1 | 2002 | 5 | 0.050 |
Why?
|
| Antigens, CD1 | 2 | 1995 | 439 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2006 | 545 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2006 | 3396 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2024 | 522 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11070 | 0.050 |
Why?
|
| CpG Islands | 1 | 2007 | 1225 | 0.050 |
Why?
|
| Mitochondria, Muscle | 1 | 2023 | 172 | 0.050 |
Why?
|
| Apoptosis | 3 | 2019 | 9468 | 0.050 |
Why?
|
| Receptors, Glucagon | 2 | 2013 | 90 | 0.050 |
Why?
|
| Young Adult | 6 | 2021 | 59068 | 0.050 |
Why?
|
| Adolescent | 8 | 2021 | 88196 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2710 | 0.050 |
Why?
|
| Prediabetic State | 1 | 2008 | 549 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2012 | 7849 | 0.050 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2001 | 30 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2022 | 191 | 0.050 |
Why?
|
| Genes, Regulator | 4 | 1994 | 374 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 94 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2008 | 4649 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 41366 | 0.050 |
Why?
|
| Disease | 1 | 2007 | 672 | 0.050 |
Why?
|
| Adenoviridae | 4 | 2000 | 1084 | 0.050 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 3 | 1999 | 32 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1725 | 0.050 |
Why?
|
| Immunoconjugates | 2 | 2000 | 953 | 0.050 |
Why?
|
| Plasmids | 9 | 2000 | 2274 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 2009 | 1060 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1993 | 419 | 0.050 |
Why?
|
| Homeodomain Proteins | 3 | 2018 | 2413 | 0.050 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 4 | 1993 | 111 | 0.050 |
Why?
|
| Nippostrongylus | 1 | 2021 | 21 | 0.050 |
Why?
|
| Lipolysis | 1 | 2022 | 210 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 256 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 10 | 2016 | 6086 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1376 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 374 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2444 | 0.050 |
Why?
|
| Membrane Glycoproteins | 3 | 1997 | 3701 | 0.050 |
Why?
|
| Nematospiroides dubius | 1 | 2021 | 37 | 0.050 |
Why?
|
| Serotonin | 1 | 2006 | 1040 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6330 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2006 | 738 | 0.050 |
Why?
|
| Salmonella enterica | 1 | 2021 | 75 | 0.050 |
Why?
|
| Citrobacter rodentium | 1 | 2021 | 65 | 0.050 |
Why?
|
| Superantigens | 2 | 1997 | 127 | 0.040 |
Why?
|
| Heart | 3 | 2008 | 4391 | 0.040 |
Why?
|
| H-Y Antigen | 2 | 1997 | 42 | 0.040 |
Why?
|
| Nanostructures | 1 | 2005 | 552 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 345 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 5 | 1983 | 555 | 0.040 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cell Movement | 3 | 2014 | 5198 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 649 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 3 | 2010 | 114 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 1737 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4549 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2002 | 616 | 0.040 |
Why?
|
| Germinal Center | 1 | 2022 | 380 | 0.040 |
Why?
|
| Time Factors | 8 | 2012 | 39947 | 0.040 |
Why?
|
| HLA-D Antigens | 2 | 1991 | 134 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 650 | 0.040 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 3076 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2021 | 42209 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4509 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3631 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2021 | 321 | 0.040 |
Why?
|
| Genes, Homeobox | 3 | 1989 | 285 | 0.040 |
Why?
|
| Lipopolysaccharides | 3 | 2014 | 2205 | 0.040 |
Why?
|
| Peptide Library | 1 | 2020 | 347 | 0.040 |
Why?
|
| Cloning, Molecular | 9 | 1997 | 4174 | 0.040 |
Why?
|
| Wound Healing | 2 | 2023 | 2799 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 36183 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2058 | 0.040 |
Why?
|
| Joint Diseases | 1 | 2002 | 459 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 642 | 0.040 |
Why?
|
| Integrin alpha4 | 1 | 2018 | 87 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1176 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 119 | 0.040 |
Why?
|
| Enterovirus B, Human | 1 | 1998 | 47 | 0.040 |
Why?
|
| Cardiotoxins | 1 | 2018 | 36 | 0.040 |
Why?
|
| DNA Probes | 2 | 2012 | 544 | 0.040 |
Why?
|
| Liver | 3 | 2019 | 7531 | 0.040 |
Why?
|
| Genes, Dominant | 3 | 2000 | 862 | 0.040 |
Why?
|
| Hippocampus | 1 | 2010 | 3755 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2002 | 444 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2001 | 1608 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 1998 | 213 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2002 | 1511 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2012 | 221 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4430 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1575 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 243 | 0.040 |
Why?
|
| Software | 1 | 2011 | 4426 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2021 | 2911 | 0.030 |
Why?
|
| Peptide Fragments | 5 | 1999 | 5105 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 6 | 1994 | 286 | 0.030 |
Why?
|
| Immunoglobulin D | 1 | 1996 | 57 | 0.030 |
Why?
|
| Viral Core Proteins | 2 | 1996 | 161 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 1997 | 140 | 0.030 |
Why?
|
| Cell Survival | 4 | 2001 | 5790 | 0.030 |
Why?
|
| Clone Cells | 6 | 2002 | 1660 | 0.030 |
Why?
|
| Rats | 2 | 2012 | 23712 | 0.030 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2017 | 119 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 36362 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2000 | 412 | 0.030 |
Why?
|
| Egg Proteins | 2 | 1999 | 57 | 0.030 |
Why?
|
| Mice, Inbred DBA | 4 | 1999 | 621 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 14002 | 0.030 |
Why?
|
| beta-Galactosidase | 4 | 1998 | 574 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 112 | 0.030 |
Why?
|
| Guanidines | 1 | 1996 | 192 | 0.030 |
Why?
|
| Animals, Newborn | 4 | 1995 | 2676 | 0.030 |
Why?
|
| Stochastic Processes | 3 | 2008 | 356 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 462 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 1995 | 67 | 0.030 |
Why?
|
| Recombination, Genetic | 4 | 2000 | 1526 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7424 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1096 | 0.030 |
Why?
|
| Recombinant Proteins | 5 | 2006 | 6525 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Muramidase | 2 | 1998 | 169 | 0.030 |
Why?
|
| Gene Targeting | 2 | 2011 | 838 | 0.030 |
Why?
|
| Spermine | 1 | 1994 | 69 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2014 | 86 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 75 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2015 | 182 | 0.030 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2180 | 0.030 |
Why?
|
| Antibody Formation | 5 | 1993 | 1397 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2010 | 2004 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2002 | 1544 | 0.030 |
Why?
|
| Somatostatin | 1 | 2015 | 447 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 1228 | 0.030 |
Why?
|
| Chromosome Deletion | 5 | 1999 | 1387 | 0.030 |
Why?
|
| Glucagon | 1 | 2015 | 532 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 220382 | 0.030 |
Why?
|
| Serum | 1 | 2014 | 210 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 1993 | 113 | 0.030 |
Why?
|
| Microcirculation | 2 | 2010 | 1269 | 0.030 |
Why?
|
| Epigenomics | 1 | 2019 | 940 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2000 | 3734 | 0.030 |
Why?
|
| Paralysis | 1 | 2014 | 250 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1886 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3800 | 0.030 |
Why?
|
| Probiotics | 1 | 2016 | 378 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 1 | 1993 | 285 | 0.030 |
Why?
|
| Cell Communication | 1 | 2020 | 1652 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 604 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 1054 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 264 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 2009 | 728 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1351 | 0.030 |
Why?
|
| Carboxypeptidases A | 1 | 2011 | 37 | 0.030 |
Why?
|
| Graft Rejection | 3 | 1994 | 4438 | 0.030 |
Why?
|
| Receptors, Neurotensin | 1 | 2012 | 16 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2016 | 708 | 0.020 |
Why?
|
| Mice, SCID | 3 | 2010 | 2625 | 0.020 |
Why?
|
| Models, Biological | 3 | 2015 | 9462 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10759 | 0.020 |
Why?
|
| Diet | 2 | 2024 | 8058 | 0.020 |
Why?
|
| Fetus | 3 | 2007 | 1863 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 4692 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1693 | 0.020 |
Why?
|
| RNA | 3 | 2018 | 2721 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 616 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1994 | 779 | 0.020 |
Why?
|
| Exons | 3 | 1992 | 2392 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2011 | 195 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 2013 | 390 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 836 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1428 | 0.020 |
Why?
|
| Streptozocin | 1 | 2011 | 193 | 0.020 |
Why?
|
| Hemagglutinins, Viral | 1 | 1990 | 66 | 0.020 |
Why?
|
| Ankle | 1 | 2014 | 349 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6297 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 2006 | 112 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 2012 | 171 | 0.020 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 2010 | 4 | 0.020 |
Why?
|
| Inbreeding | 1 | 2010 | 48 | 0.020 |
Why?
|
| Nucleotides | 1 | 1993 | 454 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 530 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2010 | 46 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 532 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1993 | 254 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2010 | 41 | 0.020 |
Why?
|
| Glycine | 1 | 1994 | 665 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 168840 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 373 | 0.020 |
Why?
|
| Epididymis | 1 | 2012 | 227 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1981 | 153 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10538 | 0.020 |
Why?
|
| Radiation Chimera | 2 | 2002 | 216 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1991 | 430 | 0.020 |
Why?
|
| Hybridization, Genetic | 2 | 2001 | 103 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2012 | 378 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3446 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 428 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2007 | 3603 | 0.020 |
Why?
|
| Albumins | 1 | 1992 | 575 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1989 | 55 | 0.020 |
Why?
|
| Amino Acids | 1 | 1996 | 1717 | 0.020 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2010 | 112 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1600 | 0.020 |
Why?
|
| Listeriosis | 1 | 2010 | 150 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1875 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 455 | 0.020 |
Why?
|
| Introns | 1 | 1992 | 981 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3609 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1990 | 240 | 0.020 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2010 | 122 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 461 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 201 | 0.020 |
Why?
|
| Cytochrome c Group | 2 | 2000 | 121 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 947 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 421 | 0.020 |
Why?
|
| Chickens | 5 | 1989 | 858 | 0.020 |
Why?
|
| Oligonucleotide Probes | 2 | 2004 | 417 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 316 | 0.020 |
Why?
|
| Structure-Activity Relationship | 5 | 1994 | 3075 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2693 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 16945 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 573 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2010 | 231 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 629 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 250 | 0.020 |
Why?
|
| Actigraphy | 1 | 2012 | 520 | 0.020 |
Why?
|
| Oligonucleotides | 2 | 2007 | 582 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 1841 | 0.020 |
Why?
|
| Biological Evolution | 2 | 1992 | 1073 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 188 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2016 | 1994 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2008 | 211 | 0.020 |
Why?
|
| Cations | 2 | 1998 | 238 | 0.020 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 396 | 0.020 |
Why?
|
| Androstadienes | 1 | 2009 | 348 | 0.020 |
Why?
|
| Mucin-6 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 575 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2044 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 1082 | 0.020 |
Why?
|
| DNA Primers | 2 | 2002 | 2820 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 877 | 0.020 |
Why?
|
| Blood | 1 | 2009 | 584 | 0.020 |
Why?
|
| Antibody Affinity | 2 | 2002 | 246 | 0.020 |
Why?
|
| Age Factors | 3 | 2018 | 18379 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2009 | 280 | 0.020 |
Why?
|
| Globins | 3 | 2000 | 403 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2441 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 694 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1999 | 94 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4936 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1596 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1649 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6230 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3842 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2388 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1999 | 818 | 0.020 |
Why?
|
| Cell Compartmentation | 2 | 1997 | 384 | 0.020 |
Why?
|
| Biological Transport | 3 | 1996 | 2090 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 1481 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 1792 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 822 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2013 | 2207 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 964 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2060 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3874 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2014 | 879 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1494 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 193 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1992 | 1058 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 934 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 727 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2014 | 2626 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3155 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 757 | 0.010 |
Why?
|
| Skin Transplantation | 3 | 1994 | 1083 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1661 | 0.010 |
Why?
|
| Mucins | 1 | 2007 | 568 | 0.010 |
Why?
|
| Macromolecular Substances | 3 | 1991 | 1435 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6128 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2011 | 2770 | 0.010 |
Why?
|
| Pedigree | 1 | 2011 | 4586 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2723 | 0.010 |
Why?
|
| Rabbits | 3 | 2000 | 4780 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 2806 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3088 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 2569 | 0.010 |
Why?
|
| Magnetics | 1 | 2005 | 599 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1994 | 982 | 0.010 |
Why?
|
| Mitosis | 1 | 2007 | 1186 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2749 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2419 | 0.010 |
Why?
|
| Brain | 4 | 1996 | 27060 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 276 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 1982 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8611 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 2 | 1995 | 656 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2911 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3637 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8163 | 0.010 |
Why?
|
| Chimera | 2 | 1994 | 453 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1981 | 134 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1991 | 422 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1991 | 780 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 1371 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2875 | 0.010 |
Why?
|
| Viral Envelope Proteins | 2 | 1996 | 640 | 0.010 |
Why?
|
| Age of Onset | 1 | 2007 | 3302 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 973 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2687 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 2035 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2005 | 2382 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4735 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 458 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3220 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 665 | 0.010 |
Why?
|
| Models, Genetic | 3 | 1997 | 3445 | 0.010 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1999 | 82 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5726 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1545 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6471 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1990 | 1141 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1989 | 853 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13616 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1128 | 0.010 |
Why?
|
| Pregnancy | 2 | 2017 | 29831 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2012 | 5078 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 269 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1807 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 1997 | 116 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1317 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 26280 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1998 | 649 | 0.010 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1998 | 289 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 555 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1998 | 1379 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1995 | 93 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 1299 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1996 | 516 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2412 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1889 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1999 | 2560 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2006 | 6380 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1494 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 1745 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12054 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1995 | 178 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1994 | 76 | 0.010 |
Why?
|
| Methotrexate | 1 | 1981 | 1720 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1981 | 2201 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8522 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 1992 | 2114 | 0.010 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1993 | 37 | 0.010 |
Why?
|
| TATA-Box Binding Protein | 1 | 1993 | 99 | 0.010 |
Why?
|
| TATA Box | 1 | 1993 | 127 | 0.010 |
Why?
|
| Submandibular Gland | 1 | 1993 | 87 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1993 | 189 | 0.010 |
Why?
|
| Ionomycin | 1 | 1993 | 110 | 0.010 |
Why?
|
| Myocardium | 2 | 1998 | 4700 | 0.010 |
Why?
|
| Nucleocapsid Proteins | 1 | 1993 | 76 | 0.010 |
Why?
|
| Capsid | 1 | 1996 | 434 | 0.010 |
Why?
|
| Microinjections | 1 | 1994 | 321 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 1993 | 150 | 0.010 |
Why?
|
| Endosomes | 1 | 1996 | 520 | 0.010 |
Why?
|
| Alanine | 1 | 1996 | 606 | 0.010 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1992 | 41 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1993 | 311 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 1230 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8579 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1996 | 563 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 4108 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 221 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 933 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 818 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1999 | 2667 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 2798 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1980 | 2846 | 0.010 |
Why?
|
| Zea mays | 1 | 1992 | 112 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1991 | 141 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1992 | 367 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1990 | 262 | 0.010 |
Why?
|
| Poly A | 1 | 1990 | 181 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1991 | 276 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1995 | 870 | 0.010 |
Why?
|
| Trypsin | 1 | 1990 | 496 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1133 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1990 | 158 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1990 | 425 | 0.010 |
Why?
|
| Fungi | 1 | 1992 | 338 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1992 | 815 | 0.010 |
Why?
|
| Horses | 1 | 1989 | 300 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2468 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 346 | 0.000 |
Why?
|
| Proteins | 2 | 1993 | 6033 | 0.000 |
Why?
|
| Gene Library | 1 | 1990 | 1059 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 299 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 58859 | 0.000 |
Why?
|
| Glutamates | 1 | 1988 | 389 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 1704 | 0.000 |
Why?
|
| Lipids | 1 | 1998 | 3342 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 1674 | 0.000 |
Why?
|
| Sheep | 1 | 1989 | 1440 | 0.000 |
Why?
|
| Homozygote | 1 | 1991 | 1794 | 0.000 |
Why?
|
| Chelating Agents | 1 | 1987 | 386 | 0.000 |
Why?
|
| Cross-Linking Reagents | 1 | 1989 | 686 | 0.000 |
Why?
|
| Stem Cell Transplantation | 1 | 1993 | 1598 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1994 | 4106 | 0.000 |
Why?
|
| Cattle | 1 | 1989 | 3849 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 80430 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1993 | 3685 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1463 | 0.000 |
Why?
|
| Kidney | 1 | 1998 | 7046 | 0.000 |
Why?
|
| Deoxyribonucleases | 1 | 1984 | 211 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1988 | 1175 | 0.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1984 | 783 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 64591 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 74055 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1983 | 2188 | 0.000 |
Why?
|
| Nucleosomes | 1 | 1984 | 484 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21322 | 0.000 |
Why?
|
| Swine | 1 | 1989 | 5915 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1979 | 1306 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 8967 | 0.000 |
Why?
|
| DNA Replication | 1 | 1984 | 1418 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1981 | 1597 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1979 | 1134 | 0.000 |
Why?
|